Research Study Collecting Blood and Tissue Samples to Understand Advanced Lung Diseases and Care After Lung Transplant

What this Trial Is About

Researchers are studying advanced lung diseases, including lung transplantation care, to better understand the effects of viral and other infectious exposures on lung transplant and chronic lung disease patients. The study supports biomarker research to identify specific indicators in blood or tissue that can help in early diagnosis and personalized treatment for conditions like interstitial lung disease, chronic obstructive lung disease COPD, and post-lung transplant rejection. Participants are observed through a biobank registry focused on lung transplant recipients. Clinical data and blood samples are collected during visits to support research on genetic risk, infectious disease susceptibility, and structural lung disease. This observational study gathers human biological specimens to advance understanding, diagnosis, and treatment of chronic lung diseases and improve post-lung transplant care. During the study, participants provide blood samples and clinical data at regular visits. Researchers track patient diagnoses and survival over five years to assess outcomes related to lung transplantation. The collected information helps evaluate biomarkers and genetic factors linked to disease progression and therapy response. Participants are monitored for long-term outcomes, contributing to ongoing research in lung health and transplant success.

Bio-Banking of Specimens for Advanced Lung Disease and Lung Transplant Research